e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oxidative stress in patients with pulmonary sarcoidosis: the role of systemic corticosteroids
A. Koutsokera, Z. Daniil, A. I. Papaioannou, T. Kiropoulos, A. Katsabeki, T. Kerenidi, K. I. Gourgoulianis (Larissa, Greece)
Source:
Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session:
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session type:
Thematic Poster Session
Number:
773
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Koutsokera, Z. Daniil, A. I. Papaioannou, T. Kiropoulos, A. Katsabeki, T. Kerenidi, K. I. Gourgoulianis (Larissa, Greece). Oxidative stress in patients with pulmonary sarcoidosis: the role of systemic corticosteroids. Eur Respir J 2007; 30: Suppl. 51, 773
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Systemic inflammation and systemic oxidative stress in acute COPD exacerbation
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Oxidative stress in patients with COPD and pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 161s
Year: 2006
Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid receptor levels
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008
Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Oxidant metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 14S-27S
Year: 2003
Drug-induced pulmonary toxicity: a role for anti-oxidants in oxidative stress
Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity
Year: 2009
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014
Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002
Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Pulmonary arterial manifestation of systemic inflammation in patients with COPD
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Uric acid, oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 428s
Year: 2006
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Oxidative stress indicators in patients with an exacerbation of COPD
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept